At a Glance
- Tasks: Lead the development of cutting-edge biomarker strategies in late-stage oncology.
- Company: Join Stryker Corporation, a leader in innovative medical technology.
- Benefits: Competitive salary, health benefits, and opportunities for professional growth.
- Other info: Collaborative environment with a focus on cross-functional leadership.
- Why this job: Make a real impact in oncology by driving innovative biomarker technologies.
- Qualifications: PhD in Life Sciences and 5+ years in the pharmaceutical industry.
The predicted salary is between 80000 - 120000 £ per year.
Stryker Corporation in Greater London is seeking a Director of Oncology Clinical Biomarkers responsible for driving the development and implementation of biomarker strategies in late-stage oncology. This role requires collaboration with Clinical Biomarker teams to establish decision-making criteria and execute patient stratification.
The ideal candidate will have a PhD in Life Sciences, a solid background in oncology biomarkers, and at least 5 years in the pharmaceutical industry, focusing on innovative biomarker technologies and cross-functional leadership.
Director, Oncology Biomarkers & Translational Medicine employer: Stryker Corporation
Stryker Corporation is an exceptional employer that fosters a collaborative and innovative work culture, particularly in the dynamic field of oncology. Located in Greater London, employees benefit from access to cutting-edge research and development opportunities, alongside a commitment to professional growth and advancement. With a focus on meaningful contributions to healthcare, Stryker offers a supportive environment where your expertise in biomarker strategies can truly make a difference.
